
New research highlights the crucial role of meninges in multiple sclerosis (MS) progression. Studies show meningeal spaces serve as access points for inflammatory cells, molecules, and antigens into the brain, impacting disease severity. Targeting meningeal inflammation may hold promise for therapeutic intervention in MS. Detailed review examines cellular, molecular, and radiological evidence, emphasizing the importance of understanding these mechanisms for clinical and therapeutic advancements.
Like
Save
Share